Medical device company Globus Medical (NYSE:GMED) announced in Q3 CY2025, with sales up 22.9% year on year to $769 million.

Medical device company LeMaitre Vascular (NASDAQ:LMAT) in Q3 CY2025, but sales rose 11.4% year on year to $61.05 million.

A seed phrase, sometimes called a recovery phrase, is a string of 12 or 24 common words that mathematically encodes a ...

A wearable device called eSight Go, on display here at Vision Expo West, assists with central vision loss in people with ...

An appeals court rejects a convicted Florida man’s claim that the U.S. government owes him over $345 million in Bitcoin.

Pulse Biosciences ( PLSE 3.81%) reported its first revenues, marking initial commercial adoption of its nPulse platform and ...

Smith+Nephew (NYSE: SNN) shares dipped before hours today on third-quarter results that failed to reach the consensus sales ...

President Donald Trump is set to host leaders of five Central Asian countries for White House talks. Thursday's summit and ...

British medical devices maker Smith+Nephew topped expectations for first-quarter sales on Thursday, buoyed by a rebound in elective surgeries and robust demand for its products.

With interest in the PlayStation Portal at an all-time high, we have just one question to answer... will it be on sale for ...

(Alliance News) - Smith & Nephew PLC on Thursday raised its annual free cash flow outlook, but shares slumped as third quarter revenue fell short of consensus.

Full-year 2025 guidance -- Revenue expected between $365 million-$375 million, non-GAAP gross margins of 78%-80%, non-GAAP ...